Search results
Catalyst (CPRX) to Gain DMD Drug Licensing Rights From Santhera
Zacks via Yahoo Finance· 10 months agoCatalyst (CPRX) announces entering into a definitive agreement to acquire licensing rights in North...
How Former IBD 50 Leader Catalyst Pharma Is Trying To Claw Back From A 29% Setback
Investor's Business Daily· 1 year agoCatalyst Pharmaceuticals added a second product to its lineup Wednesday with a $160 million deal for...
Investors in Catalyst Pharmaceuticals (NASDAQ:CPRX) have seen strong returns of 271% over the past...
Simply Wall St. via Yahoo Finance· 1 month agoThe most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But if...
No. 1 IBD 50 Stock Catalyst Tanks As Teva Looks To Knock Off Its Only Product
Investor's Business Daily· 1 year agoTeva Pharmaceutical said Monday it plans to knock off Catalyst Pharmaceuticals' only approved drug....
Catalyst Pharma, The No. 1 Tech Leader, Just Trounced Third-Quarter Expectations
Investor's Business Daily· 1 year agoCatalyst Pharmaceuticals trounced Wall Street's third-quarter forecasts and raised its full-year...
We Ran A Stock Scan For Earnings Growth And Catalyst Pharmaceuticals (NASDAQ:CPRX) Passed With Ease
Simply Wall St. via Yahoo Finance· 1 year agoFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a...
Biotech's Blockbuster Week: 3 Stocks to Watch
Zacks via Yahoo Finance· 1 year agoThis week, biotech was a standout performer. As of Friday morning, the SPDR S&P Biotech ETF XBI delivered gains of 6.42% versus gains of 1.79%. Last year...
Biotech Stock Roundup: BLUE Down on Share Issuance, CPRX Falls on Generic Filing & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in focus with key pipeline and regulatory updates. Among these, bluebird BLUE...
Zacks.com featured highlights include Tsakos Energy, AVEO Pharmaceuticals and Catalyst...
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – September 12, 2022 – Stocks in this week’s article are Tsakos...
Biotech Leader Plunges On New Offering Of 10 Million Shares
Investor's Business Daily· 4 months agoIBD Sector Leader Catalyst Pharmaceuticals plunged more than 10% on Friday after news that the...
